In pathology and laboratory billing, incorrect or obsolete lab CPT codes are a primary cause of claim denials. Are your lab test claims being delayed or denied despite following the reasons? According to the Office of Inspector General (OIG), more than 29% of laboratory claims filed to Medicare in 2023 had coding errors, most of which involved misuse of CPT codes or incorrect documentation. These errors can result in payment delays, compliance audits, or recoupments, which impact cash flow for providers and billing teams.
In 2026, the CPT update includes 270 new codes, 112 deletions, and 38 changes, with laboratory and genetic testing codes accounting for approximately 37% of all new additions—a direct response to the growth in sophisticated diagnostics and molecular testing. Practices that fail to update their charge masters and billing logic may submit incorrect claims. CMS, for example, estimated that outdated CPT use caused over $13 million in erroneous laboratory payments in 2024 alone.
This blog will guide you through the important Lab CPT Codes for 2026, including organ panels, molecular pathology, genomic sequencing, and proprietary lab analysis. You’ll learn how to use them correctly, avoid typical billing errors, and comply with CMS, AMA, and payer standards. Whether you’re a biller, programmer, or supplier, this article provides the information you need to avoid rejections and maintain your revenue.
Lab CPT Codes: 2026 Overview
Every year, laboratory CPT codes are modified to reflect changes in clinical practice, Medicare policy, and test techniques. In this section, we provide the current definition of Lab CPT Codes as well as major revisions finalized for 2026.
What Are Lab CPT Codes?
Lab CPT Codes are five-digit numeric codes used to report laboratory and pathology services for payment purposes. They specify the diagnostic tests used, such as blood counts, metabolic panels, and genetic testing. CPT codes for laboratory tests are in the 80000-89999 series.
There are four main types:
- Routine chemistry codes (e.g., 80048, 80053)
- Molecular pathology and genetic testing codes (e.g., 81203–81479)
- Proprietary Laboratory Analyses (PLA) codes (e.g., 0250U–0411U)
- Microbiology and infectious disease testing codes (e.g., 87591, 87624)
2026 Code Highlights
According to the American Medical Association, the 2026 Laboratory Billing CPT Codes will comprise 270 new codes, 112 removals, and 38 changes. Notably, 37% of new codes enable private genetic testing.
Important 2026 additions include:
- G0567: Hepatitis C screening via amplified probe
- 81195–81210: Expanded NTRK, EGFR, JAK2, and KRAS gene testing
- PLA codes 0435U–0450U: New lab-developed tests for rare conditions
Deleted codes include analyte techniques that are no longer utilized in practice. Revisions are made to test descriptions and reporting language, especially in remote monitoring and AI-assisted diagnosis.
CPT Codes for Laboratory Tests: By Category
Lab CPT Codes are separated by function and specimen type. The primary code categories most commonly used in outpatient, inpatient, and specialized practices are shown below.
Chemistry & Panels
These CPT codes refer to regularly requested lab tests for metabolic, liver, kidney, and endocrine functioning. Panels combine multiple tests into a single billing code.
| CPT Code | Description | Key Use |
| 80048 | Basic Metabolic Panel (Calcium, total) | Evaluates electrolytes, kidney function |
| 80053 | Comprehensive Metabolic Panel | Assesses liver, kidney, glucose, and more |
| 80076 | Hepatic Function Panel | Checks liver enzymes and bilirubin |
| 84443 | Thyroid Stimulating Hormone (TSH) | Screens for thyroid disorders |
| 82306 | Vitamin D, 25-hydroxy | Evaluates bone health, deficiencies |
| 84153 | Prostate-Specific Antigen (PSA), total | Prostate cancer screening |
| 82247 | Bilirubin, total | Liver and gallbladder function |
| 83735 | Magnesium | Electrolyte monitoring |
Hematology & Coagulation
These CPT codes include testing for blood counts, clotting factors, and anemia assessments. Accurate reporting ensures fair payment and compliance.
| CPT Code | Description | Key Use |
| 85025 | Complete Blood Count (CBC) with automated differential | Evaluates red/white cells, hemoglobin, and platelets |
| 85027 | CBC without differential | Basic blood profile without WBC breakdown |
| 85007 | Blood smear, microscopic examination | Assesses abnormal cells manually |
| 85730 | Partial Thromboplastin Time (PTT) | Monitors heparin test, bleeding disorders |
| 85610 | Prothrombin Time (PT) | Evaluates clotting time; warfarin monitoring |
| 85210 | Fibrinogen level | Screens for coagulation issues |
| 85652 | Sedimentation rate, non-automated | Detects inflammation |
| 86038 | Platelet antibody detection | Assesses platelet-related immune response |
Urinalysis & Drug Testing
These CPT codes include regular urinalysis, drug detection, and screening panels. Accurate code selection is required for payment and medical justification.
| CPT Code | Description | Key Use |
| 81001 | Urinalysis, automated with microscopy | Evaluates urinary tract infection or kidney issues |
| 81002 | Urinalysis, non-automated without microscopy | Basic screening without a microscopic exam |
| 81003 | Urinalysis, automated without microscopy | Common for routine health screening |
| 82043 | Microalbumin, quantitative | Detects early kidney damage |
| 82570 | Creatinine; other sources than serum | Confirms urine dilution or renal function |
| 80305 | Drug test, presumptive, any number of drug classes | Rapid screening using immunoassay |
| 80306 | Drug test, instrumented chemistry analyzer | Instrument-read testing is more reliable |
| 80307 | Drug test, definitive by instrument, e.g., LC-MS/MS | Detailed substance identification |
Microbiology & Infectious Tests
These CPT codes apply to diagnostic tests for bacterial, viral, and fungal illnesses. Proper documentation ensures that invoicing is accurate and meets payer criteria.
| CPT Code | Description | Key Use |
| 87070 | Culture, bacterial; any source, except urine, blood | Identifies bacterial organisms in clinical samples |
| 87086 | Urine culture, quantitative | Confirms urinary tract infections (UTIs) |
| 87186 | Antibiotic susceptibility test, quantitative | Determines the resistance patterns of bacteria |
| 87491 | Infectious agent detection by nucleic acid (DNA/RNA); Chlamydia trachomatis | Screens for STIs using molecular methods |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae | Molecular test for gonorrhea |
| 87635 | COVID-19 testing, amplified probe technique | Detects SARS-CoV-2 virus |
| 87804 | Influenza virus detection by immunoassay | Rapid flu testing |
| 87426 | SARS-CoV-2 antigen testing, immunoassay | Point-of-care COVID-19 antigen test |
Molecular Pathology & Genetic Testing
These CPT codes denote complicated genetic and molecular diagnostic procedures. Accurate coding helps to fund complex tests and ensures that payment rules are met.
| CPT Code | Description | Key Use |
| 81220 | CFTR gene analysis, common variants | Cystic fibrosis screening |
| 81225 | NPM1 gene analysis, common variants | Leukemia mutation testing |
| 81241 | The TP53 gene is known for familial variant analysis | Cancer risk assessment |
| 81245 | F5 (Leiden) gene mutation analysis | Thrombophilia testing |
| 81275 | HLA-DQB1 typing | Transplant compatibility |
| 81295 | MSH2 gene full sequencing | Lynch syndrome detection |
| 81301 | PMS2 gene full sequencing | Hereditary cancer testing |
| 81479 | Unlisted molecular pathology procedure | Custom/rare genetic tests not represented elsewhere |
| 81599 | Unlisted multianalyte assay with algorithmic analysis (MAAA) | Proprietary algorithm-based lab tests |
Laboratory Billing CPT Codes 2026: Rules & Avoiding Denials
In 2026, Medicare and commercial payers will approve or deny your lab claim based on the four essential categories listed below.
Modifier Use for Laboratory CPT Codes 2026
Improper modifier usage is a leading cause of lab billing rejections.
| Modifier | Description | Use Case |
| -91 | Repeat the clinical diagnostic laboratory test | Used when the same test is repeated on the same day for monitoring purposes. |
| -59 | Distinct procedural service | Applied when lab services are independent and not part of a panel |
| QW | CLIA-waived test | Used only if your lab has a valid CLIA certificate for that specific test. |
| -76 | Repeat the procedure by the same provider | Used when the same test is done again by the same provider on the same day. |
| -77 | Repeat the procedure by another provider | When a laboratory test is redone by a different supplier. |
Medical Necessity & Documentation
Medical requirements must be clearly shown in the paperwork supporting each CPT code for laboratory testing.
- A licensed practitioner must order the test to diagnose or treat
- Include the exact diagnosis (ICD-10 code) that corresponds to the ordered test.
- Ensure that the paperwork indicates how the test influences treatment or result.
- Medicare demands evidence that is legible, signed, and dated.
- Common rejections occur when screening diagnostic codes are used on non-screening testing.
MUE and UOS Limits
Medically Unlikely Edits (MUEs) and Units of Service (UOS) limitations limit the number of tests that may be invoiced each day of service.
- CMS publishes MUEs to discover billing issues and overuse.
- CPT code 80061 (Lipid Panel) has a UOS of one; invoicing more may result in refusal.
- Do not divide tests across days to avoid MUEs; this might lead to fraud problems.
- Always double-check lab-specific UOS guidelines in the Medicare Clinical Laboratory Fee Schedule.
Fee Schedule & Payment Changes
Learn what has changed in payment rates and lab billing regulations for 2026.
- The April 2026 CLFS update included and eliminated CPT codes for proprietary and genetic testing.
- CMS continues to block cutbacks for most CDLTs under PAMA until 2026, although accurate reporting is still required.
- New codes, as G0567 for Hepatitis C screening, were created and will be MAC-priced until CMS assigns national values.
- Payment reductions for non-ADLTs will begin in 2026, with a new 15% annual cap.
Conclusion
Keeping up with 2026 Lab CPT Codes is crucial for appropriate billing, proper reimbursement, and compliance with payer criteria. Misuse of codes and modifiers remains a major basis for rejections. Documentation must demonstrate medical need and coding correctness. With regular CMS and AMA modifications, outdated practices might lead to income loss. Use this guidance to ensure billing correctness and save unnecessary rework.
FAQs
What are Lab CPT Codes used for?
Lab CPT Codes are used to report laboratory and pathology procedures for billing and reimbursement purposes.
What’s new in Lab CPT Codes for 2026?
The 2026 update comprises 270 new codes, 37% of which relate to genetic and molecular testing upgrades.
Why are my lab claims being denied?
Common causes include obsolete CPT codes, missing modifiers, and a lack of medical necessity documentation..
How do I avoid lab billing denials in 2026?
Use the correct CPT codes, apply appropriate modifiers, and ensure documentation supports the test performed.
Are there restrictions on how many times a lab test may be billed?
Yes, MUEs and UOS limits define how often a test can be billed per day and must be followed to avoid denials.
